8-K: 60 Degrees Pharma Secures $1.4M ATM Equity Facility

60 Degrees Pharmaceuticals establishes a new At-The-Market equity offering for up to $1.4 million, replacing a prior agreement.

Summary

• 60 Degrees Pharmaceuticals, Inc. entered into an At-The-Market (ATM) Sales Agreement with H.C. Wainwright & Co., LLC on September 3, 2025.
• The agreement allows the company to offer and sell shares of its common stock for aggregate gross sales proceeds of up to $1,397,533.
• H.C. Wainwright & Co., LLC will act as sales agent or principal, receiving a commission of 3.0% of gross proceeds from each sale.
• Sales will be made by methods permitted for at-the-market offerings, including on Nasdaq or through privately negotiated transactions with company approval.
• The company has no obligation to sell any shares and can suspend or terminate the agreement at any time.
• This new agreement replaces a previous ATM Issuance Sales Agreement with Wallachbeth Capital LLC, which was terminated effective September 3, 2025, with a waiver of the 10-day notice period.
• The shares will be issued under the company's shelf registration statement on Form S-3, effective July 18, 2024.

Sentiment

Score: 5

Explanation: The filing describes a standard financing mechanism (ATM offering) which provides capital flexibility but also carries potential for dilution. It's a neutral event in terms of immediate operational performance.

Positives

• Provides the company with flexible access to capital for general corporate purposes.
• Allows the company to raise funds opportunistically based on market conditions.
• The company retains control over the timing and amount of shares sold.

Negatives

• Potential for shareholder dilution if shares are sold under the ATM program.
• The 3.0% commission to the sales agent reduces the net proceeds to the company.
• The relatively small maximum amount of $1,397,533 suggests limited immediate capital needs or market capacity.

Risks

• Dilution Risk: Future sales of common stock under the ATM agreement will dilute the ownership interest of existing shareholders.
• Market Price Volatility: The price at which shares are sold will depend on market conditions, which could be unfavorable.
• Uncertainty of Proceeds: There is no guarantee that the company will sell any shares or raise the full amount, as sales are discretionary.

Future Outlook

The company gains the ability to raise up to $1,397,533 in capital through the sale of common stock at market prices, providing financial flexibility for general corporate purposes as outlined in its prospectus. The timing and amount of any sales will be at the company's discretion, subject to market conditions.

Management Comments

• The company has no obligation to sell any of the ATM Shares and may at any time suspend offers under the Sales Agreement or terminate the Sales Agreement.

Industry Context

At-the-market (ATM) offerings are a common financing tool for publicly traded companies, particularly those in the biotechnology or pharmaceutical sectors like 60 Degrees Pharmaceuticals, which may require ongoing capital for research, development, and operational expenses. These facilities provide a flexible and cost-effective way to raise capital incrementally, avoiding the larger, more disruptive capital raises that can be necessary for smaller companies. The termination of one ATM and initiation of another suggests a strategic decision to optimize financing partners or terms.

Legal Proceedings

• The legal opinion from Sichenzia Ross Ference Carmel LLP confirms the legality of the issuance and sale of the ATM Shares. No new litigation or regulatory matters are disclosed.

Stakeholder Impact

• Shareholders: Potential for dilution of existing shareholdings if the company sells shares under the ATM program.
• Company: Enhanced financial flexibility to fund operations, research, and development.

Next Steps

• The company may, from time to time, offer and sell shares of common stock under the ATM Sales Agreement.
• H.C. Wainwright & Co., LLC will use commercially reasonable efforts to sell shares based on the company's instructions.

Key Dates

Keywords

60 Degrees Pharmaceuticals, ATM Offering, Equity Raise, Common Stock, H.C. Wainwright & Co., Capital Markets, SEC Filing, Form 8-K, Dilution, Nasdaq